Nexgel NXGL
NASDAQ NXGL
$5.45 +0.12 (+2.25%)
As of: Oct 21, 2026 · 1:41 PM EDT

Nexgel (NXGL) EPS (Basic) (2018 - 2026)

Updated

Nexgel (NXGL) reported EPS (Basic) of -$0.40 for Q2 2026, compared with -$0.09 a year earlier.

Analysis

Nexgel (NXGL) EPS (Basic) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nexgel's EPS (Basic) came in at -$0.66; for FY2025, it came in at -$0.38.

  • By year, EPS (Basic) came in at -$0.50 in FY2024, -$0.56 in FY2023, -$0.85 in FY2022 and -$1.45 in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Basic) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Iqvia Holdings 45.60 Bn 37.30 Bn 1.44 Bn 1.54
2 Medpace Holdings 18.41 Bn 16.48 Bn 201.64 Mn 4.31
3 Charles River Laboratories International 16.62 Bn 15.81 Bn 363.37 Mn -0.03
4 Icon 14.56 Bn 11.67 Bn 479.29 Mn 0.93
5 Fortrea Holdings 2.25 Bn 1.63 Bn 139.20 Mn -0.14
6 Ginkgo Bioworks Holdings 618.46 Mn -143.62 Mn 18.44 Mn -0.75
7 Evotec SE 552.27 Mn -1.06 Bn - -
8 Champions Oncology 67.82 Mn 42.90 Mn 7.70 Mn -0.03
9 MindWalk Holdings 60.30 Mn 23.95 Mn 1.61 Mn -0.09
10 Nexgel 2.46 Mn -1.97 Mn 1.11 Mn -8.07
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.07
Dec 31, 2025 -2.47
Sep 30, 2025 -1.64
Jun 30, 2025 -1.74
Mar 31, 2025 -1.86
Dec 31, 2024 -2.61
Sep 30, 2024 -2.11
Jun 30, 2024 -2.83
Mar 31, 2024 -2.85
Dec 31, 2023 -3.87
Sep 30, 2023 -1.92
Jun 30, 2023 -2.45
Mar 31, 2023 -2.91
Dec 31, 2022 -2.32
Sep 30, 2022 -4.40
Jun 30, 2022 -3.71
Mar 31, 2022 -6.59
Dec 31, 2021 -11.00
Sep 30, 2021 -7.67
Jun 30, 2021 -5.61
API Access

Nexgel EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=NXGL&period=max&api_key=YOUR_API_KEY